Global Biologics Consulting Services Market Size & Trends Report Segmented by Phase (Preclinical, Clinical, Commercial), Product type (mABs, Vaccines, CGT, Biosimilars, ADCs, Oligonucleotide Therapies), End User & Regional Forecast to 2030

This report by Medi-Tech Insights provides the size of the global biologics consulting services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on phase, product type, and end user.

Market Size & Forecast (2023-2030), By Phase, USD Million

• Preclinical
• Clinical
• Commercial

Market Size & Forecast (2023-2030), By Product Type, USD Million

• Monoclonal Antibodies (mABs)
• Vaccines
• Cell Therapies and Gene Therapies
• Biosimilars
• Fusion Proteins and ADCs
• Oligonucleotide Therapies
• Others

Market Size & Forecast (2023-2030), By End User, USD Million

• Biopharmaceutical Companies
• Academind Research Institutions
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa